Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency

Triheptanoin improves brain energy metabolism in patients with Huntington disease

(2015) I. M. Adanyeguh et al.   NEUROLOGY

Triheptanoin for Glucose Transporter Type I Deficiency (G1D)

(2014) Juan M. Pascual et al.   JAMA Neurology

Glut1 Deficiency Syndrome and Novel Ketogenic Diets

(2013) Joerg Klepper et al.   JOURNAL OF CHILD NEUROLOGY

Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease

(2013) Jeremy S. Francis et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy

(2013) Mussie G. Hadera et al.   JOURNAL OF NEUROCHEMISTRY

GLUT1 deficiency syndrome: An update

(2013) D. Gras et al.   REVUE NEUROLOGIQUE

Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy

(2012) Tae Hwan Kim et al.   EPILEPSY RESEARCH

Heptanoate as a Neural Fuel: Energetic and Neurotransmitter Precursors in Normal and Glucose Transporter I-Deficient (G1D) Brain

(2012) Isaac Marin-Valencia et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Abnormal response to cortical activation in early stages of Huntington disease

(2012) Fanny Mochel et al.   MOVEMENT DISORDERS

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder

(2010) W. G. Leen et al.   BRAIN

The spectrum of movement disorders in Glut-1 deficiency

(2010) Roser Pons et al.   MOVEMENT DISORDERS